Partners
CIMT collaborates with major international organizations like the Cancer Immunotherapy Consortium of the Cancer Research Institute (CRI-CIC) and the American Association for Cancer Research (AACR). CIMT is a FOCIS members society and maintains a partnership with the Japanese Association for Cancer Immunotherapy (JACI). Furthermore, CIMT cooperates with the journal Cancer Immunology Immunotherapy (CII).
CIMT is also a dissemination platform for GAPVAC, the EU funded Glioma Actively Personalized Vaccine Consortium.
